FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1874493808> ?p ?o ?g. }

• W1874493808 endingPage "472" @default.
• W1874493808 startingPage "461" @default.
• W1874493808 abstract "Even when treated with telaprevir-based triple therapy, some patients fail to achieve a sustained virological response. This study identified factors related closely to treatment failure. A total of 146 Japanese genotype 1b chronic hepatitis C patients were enrolled in this prospective, multicenter study and received a 24-week regimen of triple therapy. The end-of-treatment response rate was significantly lower in patients with the interleukin 28B (IL28B) (rs8099917) non-TT genotype (85.2%) than in those with the TT genotype (100%, P = 0.0002). Multiple logistic regression analysis identified high α-fetoprotein levels as an independent factor related to non-end-of-treatment response in patients with the non-TT genotype. A cut-off value of 20 ng/ml was determined for a non-end-of-treatment response; sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were 75.0%, 95.7%, 75.0%, 75.0%, and 92.6%, respectively. Multiple logistic regression analysis for a sustained virological response identified the IL28B TT genotype, low α-fetoprotein levels, non-responders, and a rapid virological response. The sustained virological response rate was significantly lower in patients with the non-TT genotype (59.3%) than in those with the TT genotype (96.7%, P < 0.0001). In patients with the non-TT genotype, α-fetoprotein was the most significant predictor for non-sustained virological response by univariate analysis. A cut-off value of 7.4 ng/ml α-fetoprotein was determined for non-sustained virological response; sensitivity, specificity, PPV, NPV, and accuracy were 63.6%, 87.5%, 77.8%, 77.8%, and 77.8%, respectively. For the non-TT patients, serum α-fetoprotein levels may be a surrogate marker for predicting treatment failure in telaprevir-based therapy for genotype 1b chronic hepatitis C." @default.
• W1874493808 created "2016-06-24" @default.
• W1874493808 creator A5000519458 @default.
• W1874493808 creator A5002683542 @default.
• W1874493808 creator A5009887722 @default.
• W1874493808 creator A5033801155 @default.
• W1874493808 creator A5050080287 @default.
• W1874493808 creator A5055227838 @default.
• W1874493808 creator A5065975345 @default.
• W1874493808 creator A5073807260 @default.
• W1874493808 creator A5080709934 @default.
• W1874493808 creator A5085648916 @default.
• W1874493808 creator A5086743926 @default.
• W1874493808 date "2013-10-28" @default.
• W1874493808 modified "2023-10-17" @default.
• W1874493808 title "α-Fetoprotein is a surrogate marker for predicting treatment failure in telaprevir-based triple combination therapy for genotype 1b chronic hepatitis C Japanese patients with the<i>IL</i><i>28</i><i>B</i>minor genotype" @default.
• W1874493808 cites W115961406 @default.
• W1874493808 cites W1602211677 @default.
• W1874493808 cites W1703975237 @default.
• W1874493808 cites W1760890369 @default.
• W1874493808 cites W1887558851 @default.
• W1874493808 cites W1971365333 @default.
• W1874493808 cites W1978892007 @default.
• W1874493808 cites W1979174109 @default.
• W1874493808 cites W1994850200 @default.
• W1874493808 cites W2002065331 @default.
• W1874493808 cites W2008050329 @default.
• W1874493808 cites W2013256718 @default.
• W1874493808 cites W2016205218 @default.
• W1874493808 cites W2026347117 @default.
• W1874493808 cites W2026614040 @default.
• W1874493808 cites W2027179322 @default.
• W1874493808 cites W2027545702 @default.
• W1874493808 cites W2032509820 @default.
• W1874493808 cites W2055818657 @default.
• W1874493808 cites W2056418842 @default.
• W1874493808 cites W2060895146 @default.
• W1874493808 cites W2062414266 @default.
• W1874493808 cites W2063285149 @default.
• W1874493808 cites W2070348315 @default.
• W1874493808 cites W2075282196 @default.
• W1874493808 cites W2084119969 @default.
• W1874493808 cites W2086414517 @default.
• W1874493808 cites W2088596257 @default.
• W1874493808 cites W2089128362 @default.
• W1874493808 cites W2095350255 @default.
• W1874493808 cites W2100485606 @default.
• W1874493808 cites W2100797437 @default.
• W1874493808 cites W2107512529 @default.
• W1874493808 cites W2107639148 @default.
• W1874493808 cites W2109235725 @default.
• W1874493808 cites W2114376411 @default.
• W1874493808 cites W2114730077 @default.
• W1874493808 cites W2116848809 @default.
• W1874493808 cites W2119764771 @default.
• W1874493808 cites W2122216714 @default.
• W1874493808 cites W2125963799 @default.
• W1874493808 cites W2127685726 @default.
• W1874493808 cites W2130113454 @default.
• W1874493808 cites W2133513652 @default.
• W1874493808 cites W2141214317 @default.
• W1874493808 cites W2334739841 @default.
• W1874493808 cites W2335845212 @default.
• W1874493808 cites W4295332460 @default.
• W1874493808 doi "https://doi.org/10.1002/jmv.23824" @default.
• W1874493808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24166425" @default.
• W1874493808 hasPublicationYear "2013" @default.
• W1874493808 type Work @default.
• W1874493808 sameAs 1874493808 @default.
• W1874493808 citedByCount "7" @default.
• W1874493808 countsByYear W18744938082013 @default.
• W1874493808 countsByYear W18744938082014 @default.
• W1874493808 countsByYear W18744938082015 @default.
• W1874493808 countsByYear W18744938082018 @default.
• W1874493808 crossrefType "journal-article" @default.
• W1874493808 hasAuthorship W1874493808A5000519458 @default.
• W1874493808 hasAuthorship W1874493808A5002683542 @default.
• W1874493808 hasAuthorship W1874493808A5009887722 @default.
• W1874493808 hasAuthorship W1874493808A5033801155 @default.
• W1874493808 hasAuthorship W1874493808A5050080287 @default.
• W1874493808 hasAuthorship W1874493808A5055227838 @default.
• W1874493808 hasAuthorship W1874493808A5065975345 @default.
• W1874493808 hasAuthorship W1874493808A5073807260 @default.
• W1874493808 hasAuthorship W1874493808A5080709934 @default.
• W1874493808 hasAuthorship W1874493808A5085648916 @default.
• W1874493808 hasAuthorship W1874493808A5086743926 @default.
• W1874493808 hasConcept C104317684 @default.
• W1874493808 hasConcept C121608353 @default.
• W1874493808 hasConcept C126322002 @default.
• W1874493808 hasConcept C135763542 @default.
• W1874493808 hasConcept C141341695 @default.
• W1874493808 hasConcept C144301174 @default.
• W1874493808 hasConcept C151956035 @default.
• W1874493808 hasConcept C203014093 @default.
• W1874493808 hasConcept C2522874641 @default.
• W1874493808 hasConcept C2776408679 @default.
• W1874493808 hasConcept C2778159067 @default.
• W1874493808 hasConcept C2780040827 @default.

• next